The Future of Gene Therapy: A Review of In Vivo and Ex Vivo Delivery Methods for Genome Editing-Based Therapies
Molecular Biotechnology · 2025-02 · 67 (2) · 425-437
DOI: 10.1007/s12033-024-01070-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biotechnology, online erschienen am 16.02.2024. Verfasst von Olga Volodina und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, 115522, Russia. volodold@gmail.com. Hauptthemen laut MEDLINE: Gene Editing, Genetic Therapy, Gene Transfer Techniques. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
The development of gene therapy based on genome editing has opened up new possibilities for the treatment of human genetic disorders. This field has developed rapidly over the past few decades, some genome editing-based therapies are already in phase 3 clinical trials. However, there are several challenges to be addressed before widespread adoption of gene editing therapy becomes possible. The main obstacles in the development of such therapy are safety and efficiency, so one of the biggest issues is the delivery of genetic constructs to patient cells. Approaches in genetic cargo delivery divide into ex vivo and in vivo, which are suitable for different cases. The ex vivo approach is mainly used to edit blood cells, improve cancer therapy, and treat infectious diseases. To edit cells in organs researches choose in vivo approach. For each approach, there is a fairly large set of methods, but, unfortunately, these methods are not universal in their effectiveness and safety. The focus of this article is to discuss the current status of in vivo and ex vivo delivery methods used in genome editing-based therapy. We will discuss the main methods employed in these approaches and their applications in current gene editing treatments under development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, 115522, Russia. volodold@gmail.com.
- Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, 115522, Russia.
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Volodina, O., & Smirnikhina, S. (2025). The Future of Gene Therapy: A Review of In Vivo and Ex Vivo Delivery Methods for Genome Editing-Based Therapies. Molecular Biotechnology, 67(2), 425-437. https://doi.org/10.1007/s12033-024-01070-4
Vancouver
Volodina O, Smirnikhina S. The Future of Gene Therapy: A Review of In Vivo and Ex Vivo Delivery Methods for Genome Editing-Based Therapies. Molecular Biotechnology. 2025;67(2):425-437. doi:10.1007/s12033-024-01070-4
BibTeX
@article{Volodina2025,
author = {Volodina, Olga and Smirnikhina, Svetlana},
title = {The Future of Gene Therapy: A Review of In Vivo and Ex Vivo Delivery Methods for Genome Editing-Based Therapies},
journal = {Molecular Biotechnology},
year = {2025},
volume = {67},
number = {2},
pages = {425--437},
doi = {10.1007/s12033-024-01070-4}
}
EUVIMED